Package 65862-036-10

{"route": ["ORAL"], "spl_id": "c4e0edda-dad5-4bed-b108-b6aae30e3be3", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95", "4B9XT59T7S"], "rxcui": ["200082"], "spl_set_id": ["d40292ff-046c-4a04-b801-10768667951a"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (65862-036-10)  / 10 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "65862-036-10", "marketing_start_date": "20170505"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (65862-036-60)", "package_ndc": "65862-036-60", "marketing_start_date": "20170505"}], "brand_name": "Lamivudine and Zidovudine", "product_id": "65862-036_c4e0edda-dad5-4bed-b108-b6aae30e3be3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "65862-036", "generic_name": "Lamivudine and Zidovudine", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine and Zidovudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "150 mg/1"}, {"name": "ZIDOVUDINE", "strength": "300 mg/1"}], "application_number": "ANDA077558", "marketing_category": "ANDA", "marketing_start_date": "20170505", "listing_expiration_date": "20261231"}